National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 1/29/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Incyte

None

None

4/5/2013

Mojtaba Akhtari, MD

None

None

None

None

5/15/2013

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Astellas;
Clavis;
Cyclacel;
CytRx

Celgene Corporation;
Astellas;
Teva

None

None

5/19/2013

Ellin Berman, MD

Ariad Pharmaceuticals

None

None

None

1/22/2013

Adam D. Cohen, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation

None

Celgene Corporation

8/13/2012

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

3/16/2012

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

None

None

5/14/2013

Amir T. Fathi, MD

None

Genzyme Corporation;
Seattle Genetics;
Teva Pharmaceuticals

None

Concert Pharma

9/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

11/8/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Madan Jagasia, MD

None

None

None

None

4/1/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

8/24/2012

Susan O'Brien, MD

Hana Biosciences, Inc.

Hana Biosciences, Inc.

None

None

8/31/2012

Arnel Pallera, MD

None

None

None

None

4/16/2012

Javier Pinilla-Ibarz, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

4/20/2012

Jerald P. Radich, MD

Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

1/29/2013

Vishnu VB. Reddy, MD

None

None

None

None

10/11/2012

Neil P. Shah, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company

None

None

5/2/2011

Paul J. Shami, MD

Eisai Inc.;
Genzyme Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/28/2013

B. Douglas Smith, MD

None

ARIAD Pharmaceuticals, Inc.;
Clavis;
TEVA

None

None

1/19/2013

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

2/27/2013

Hema Sundar, PhD

None

None

None

None

2/25/2013

Meir Wetzler, MD

Amgen Inc.;
Bristol-Myers Squibb Company

Amgen Inc.;
Teva

None

None

8/7/2012